Storan Tablet 10 mg (Lafutidine)

Adult dose

1. Short-term treatment of gastric ulcers: The usual dose is 10mg of lafutidine orally twice daily, in the morning and at bedtime. Clinical trials of treatment for up to 8 weeks showed that most ulcers healed within 8 weeks, although healing time may vary among patients. 2. Short-term treatment of duodenal ulcers: The usual dose is 10mg of lafutidine orally twice daily, in the morning and at bedtime. Clinical trials of treatment for up to 6 weeks showed that most ulcers healed within 6 weeks, although healing time may vary among patients. 3. Improvement of gastric mucosal lesions in acute and chronic gastritis: The usual dose is 10mg of lafutidine orally once daily at bedtime. Clinical trials of treatment for up to 2 weeks showed that most lesions healed within 2 weeks, although healing time may vary among patients. 4. Combination therapy with antibiotics in patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. 5. Premedication before anesthesia: The usual dose is 10mg of lafutidine orally twice (at bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer 10mg of lafutidine orally twice daily.

This medication should not be used by individuals allergic to its components. This drug contains lactose, so individuals with a genetic disorder that prevents proper digestion of lactose should not use it. Caution should be exercised for individuals with a history of allergies, liver or kidney dysfunction, those undergoing dialysis, and elderly individuals. When using this drug, careful observation is required as allergic reactions may present with symptoms such as pallor, decreased blood pressure, and difficulty breathing. Liver function should be monitored as abnormalities or symptoms of jaundice may arise. Serious side effects such as agranulocytosis or thrombocytopenia resulting in decreased blood cell counts may occur, and usage should be immediately stopped if symptoms arise. Rarely, various side effects such as skin rash, convulsions, and cardiac problems have been reported, so immediate consultation with healthcare professionals is necessary if abnormal symptoms occur. This medication may mask symptoms of malignant tumors such as gastric cancer, so testing must occur if symptoms are suspected. In particular, if gastric cancer is suspected, the use of this medication must be discontinued after confirming the presence of malignancy during initial examinations. Throughout treatment, the patient’s condition, blood, liver, and kidney function should be regularly monitored, only using the minimal duration necessary. Elderly individuals may exhibit reduced physiological function; thus, careful attention to dosage and administration intervals is required. Patients undergoing dialysis may experience increased blood concentration of this drug, so starting with a lower dosage is advisable. Pregnant women or those who may become pregnant should use this medication only if the benefits outweigh the risks under a doctor's judgment, while breastfeeding women are advised not to use it. The safety of this medication in children has not been established, so its use is not recommended. This drug should be stored out of reach of children and kept in its original container; transferring to another container is not allowed. While this drug has not shown carcinogenicity in animal studies, some changes in endocrine cells have been observed at high doses. Moreover, some side effects have been reported in animals at high doses, but fetal malformations or growth disabilities were not observed.

• Shock
• symptoms of anaphylaxis
• facial pallor
• hypotension
• generalized rash
• dyspnea
• liver dysfunction
• jaundice
• agranulocytosis
• pharyngitis

This medication is susceptible to air and moisture, so it must be stored in a tightly sealed container. Additionally, it should be stored at room temperature between 1°C and 30°C, avoiding extremes of heat or cold.

Appearance

White circular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle